LakeShore Biopharma Co Ltd (LSB)
2.71
-0.39
(-12.58%)
USD |
NASDAQ |
Nov 14, 16:00
2.71
0.00 (0.00%)
After-Hours: 17:03
LakeShore Biopharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.9778 |
| June 30, 2023 | 0.7793 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.4709 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.4709
Minimum
Sep 2022
0.9778
Maximum
Sep 2023
0.4287
Average
0.7793
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0358 |
| CASI Pharmaceuticals Inc | 2.047 |
| Zai Lab Ltd | 0.0998 |
| China SXT Pharmaceuticals Inc | 0.1731 |
| Adagene Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 220.84M |
| Total Liabilities (Quarterly) | 144.48M |
| Shareholders Equity (Quarterly) | 76.35M |